Mega Genomics Limited (HKG:6667)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
7.20
-0.05 (-0.69%)
Mar 31, 2025, 3:45 PM HKT
-0.69%
Market Cap1.61B
Revenue (ttm)171.61M
Net Income (ttm)34.27M
Shares Out224.30M
EPS (ttm)0.17
PE Ratio43.30
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume2,200
Average Volume5,480
Open7.30
Previous Close7.25
Day's Range7.20 - 7.30
52-Week Range5.98 - 11.98
Beta1.00
RSI46.97
Earnings DateAug 29, 2025

About Mega Genomics

Mega Genomics Limited, a genetic testing platform company, provides consumer genetic testing and cancer screening services in China. It offers general testing services, including brain health assessment package, a service that assesses the risk of various related diseases, including Alzheimer’s disease; alimentation capability assessment package, a service that assesses the risk of developing hyperhomocysteinemia; Parkinson’s disease risk assessment; full-scale cancer risk assessment packages; and cardiovascular and cerebrovascular disease risk... [Read more]

Sector Healthcare
Founded 2016
Employees 229
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 6667
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.